---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-126763"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2021-10-15T23:59:59+00:00"
generated_at: "2026-06-28T20:36:29.011380+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Johan Christenson resigns from Aprea Therapeutics board

## Summary
- Johan Christenson, M.D., Ph.D. resigned from the Board of Directors effective upon filing of Q3 2021 Form 10-Q.
- Resignation is not due to any disagreement with the company's operations, policies, or practices.
- No replacement director has been announced yet.

## SEC filing metadata
- accession: 0001104659-21-126763
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2021-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465921126763/0001104659-21-126763-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465921126763/tm2130064d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-126763
- JSON: https://secwatch.observer/filing/0001104659-21-126763.json
- Plain text: https://secwatch.observer/filing/0001104659-21-126763.txt

## Key facts
- Executive change
  Johan Christenson resigned as Director at Aprea Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On October 13, 2021, Johan Christenson, M.D., Ph.D. resigned from the Board of Directors of the Company, effective upon the Company’s filing of its Form 10-Q for the third quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1781983/000110465921126763/0001104659-21-126763-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.